Publications
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)2023 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Komentář ke studii2023 | First Faculty of Medicine
- CheckMate 9LA trial: commentary and clinical case report of patient with cerebellar metastasis2023 | First Faculty of Medicine
- Cemiplimab: monotherapy and combination therapy of NSCLC - analysis of locally advanced disease2023 | First Faculty of Medicine
- Immunotherapy associated pulmonary toxicity: pneumonitis2023 | First Faculty of Medicine
- Komentář k analýze2023 | First Faculty of Medicine
- Indikace durvalumabu v léčbě pacientů s bronchogenním karcinomem2023 | First Faculty of Medicine
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Loading network view...